Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-8,150
Closed -$395K 89
2017
Q3
$395K Sell
8,150
-2,800
-26% -$172K 0.19% 66
2017
Q2
$734K Sell
10,950
-1,734
-14% -$116K 0.37% 53
2017
Q1
$829K Sell
12,684
-925
-7% -$63.8K 0.42% 52
2016
Q4
$997K Sell
13,609
-316
-2% -$22.6K 0.51% 48
2016
Q3
$1.01M Sell
13,925
-7,750
-36% -$566K 0.53% 47
2016
Q2
$1.64M Sell
21,675
-9,800
-31% -$687K 0.85% 40
2016
Q1
$2.21M Hold
31,475
1.17% 33
2015
Q4
$1.9M Buy
31,475
+1,025
+3% +$60.1K 1.21% 31
2015
Q3
$1.71M Buy
30,450
+16,450
+118% +$882K 1.22% 26
2015
Q2
$709K Buy
+14,000
New +$739K 0.47% 62

Other funds holding SCG

Hamel Associates's SCG Position: Q4 2017 in Review

Hamel Associates sold out of Scana (SCG) in Q4 2017, closing a stake of 8,150 shares — an estimated $395K sold.

Hamel Associates first reported a position in SCG in Q2 2015 and held it in 10 quarters. The position peaked at $2.21M in Q1 2016. 480 funds tracked by Wall St. Rank hold SCG as of Q4 2017.

  • Hamel Associates reported no remaining Scana position as of Q4 2017 after selling out during the quarter.
  • Hamel Associates sold 8,150 Scana shares in Q4 2017, an estimated $395K.
  • Hamel Associates first reported a position in Scana in Q2 2015 and held it in 10 quarters.
  • Hamel Associates's Scana position peaked at $2.21M in Q1 2016.
  • 480 funds tracked by Wall St. Rank held Scana as of Q4 2017.

Based on Hamel Associates's 13F filing for Q4 2017, filed 13 Feb 2018.